What the company does
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
What the weekly tape is saying
ALECR closed the latest completed week at 15,300 EUR. The 4-week return is -3.8% and the 12-week return is -15.0%. Trend Signal is inactive, Market Dynamics is -0.16. Setup signature: Risk-first tape with a 25/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 16,620 EUR
- Vs Trend Line
- -7.9%
- Fair Value
- 20,924 EUR
- Vs Fair Value
- -26.9%
- 52W High
- 20,600 EUR
- 52W Low
- 15,300 EUR
- Drawdown
- -25.7%
- Range Position
- 0.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 2
- 52W Active Breadth
- 3.8%
- Sector Scope
- FR Healthcare
- Sector Rank
- 73 of 76
- Sector Percentile
- 4.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 37 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Diagnostics & Research
- Tracked Peers
- 6
- 4W Rank
- 3 of 6
- Avg 1W
- -3.8%
- Avg 4W
- -2.2%
- Trend Breadth
- 16.7%
- Positive RS
- 16.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.16
- 4W MD Change
- 68.6%
- Relative Strength
- -14.31
- 4W RS Change
- -62.8%
- Expectation
- Negative
- Probability
- 20.33%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1
- 13W Average
- 1
- 52W Average
- 2
- Vs 13W
- 1.0x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.3%
- 52W Volatility
- 5.2%
- Upside Weeks
- 12
- Downside Weeks
- 11
- Downside Breadth
- 21.2%
- Avg Gain / Loss
- 5.3% / -7.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- EUR
- Market Cap
- 80.2M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 15,300 EUR | -11.6% | 16,620 EUR | 20,924 EUR | -0.16 | -14.31 | 1 | Off |
| 5 Jun 2026 | 17,300 EUR | 8.8% | 16,647 EUR | 21,012 EUR | -0.13 | -2.29 | 3 | Off |
| 29 May 2026 | 15,900 EUR | 0.0% | 16,607 EUR | 21,087 EUR | -0.49 | -10.25 | 1 | Off |
| 22 May 2026 | 15,900 EUR | 0.0% | 16,613 EUR | 21,171 EUR | -0.44 | -10.07 | 1 | Off |
| 15 May 2026 | 15,900 EUR | 0.0% | 16,673 EUR | 21,254 EUR | -0.51 | -8.79 | 0 | Off |
| 8 May 2026 | 15,900 EUR | 0.0% | 16,730 EUR | 21,338 EUR | -0.58 | -11.07 | 1 | Off |
| 1 May 2026 | 15,900 EUR | 0.6% | 16,787 EUR | 21,422 EUR | -0.63 | -11.63 | 2 | Off |
| 24 Apr 2026 | 15,800 EUR | 0.0% | 16,863 EUR | 21,506 EUR | -0.74 | -13.17 | 0 | Off |
| 17 Apr 2026 | 15,800 EUR | 0.0% | 16,943 EUR | 21,591 EUR | -0.60 | -16.50 | 0 | Off |
| 10 Apr 2026 | 15,800 EUR | 2.6% | 17,023 EUR | 21,676 EUR | -0.15 | -15.52 | 1 | Off |
| 3 Apr 2026 | 15,400 EUR | -2.5% | 17,103 EUR | 21,732 EUR | 0.25 | -15.29 | 1 | Off |
| 27 Mar 2026 | 15,800 EUR | -12.2% | 17,197 EUR | 21,791 EUR | 0.73 | -10.83 | 2 | Off |
| 20 Mar 2026 | 18,000 EUR | 0.0% | 17,283 EUR | 21,847 EUR | 0.78 | 1.60 | 0 | Off |
| 13 Mar 2026 | 18,000 EUR | 0.0% | 17,297 EUR | 21,890 EUR | 0.83 | -1.73 | 0 | Off |